Moderna extends losses as R&D Day updates lead to downgrades

Moderna Extends Losses As R&D Day Updates Lead To Downgrades

2 weeks from now

Following an over 12% decline in the previous session in reaction to updates at the company’s R&D Day event, Moderna (NASDAQ:MRNA) shares continued to tumble in the pre-market on …

msn.com

Moderna's Spending Cuts, Pipeline Shakeup Leave Doubts About A …

2 weeks from now

Sep 13, 2024  · Moderna's stock (MRNA) was down 4% Friday morning, after a 12% drop on Thursday. Some analysts are skeptical that Moderna's efforts to expand the label for its RSV …

morningstar.com

Moderna’s CEO Sees An ‘Evolution Of Strategy.’ The Stock ... - MSN

2 weeks from now

Shares finished the day down 12.4% to $69.68, the lowest close since August 2020. Moderna says those cuts will bring it to break even on an operating cash cost basis in 2028.

msn.com

Moderna Faces Analyst Downgrades Amid Revised R&D …

2 weeks from now

Sep 13, 2024  · Thursday, Moderna Inc (NASDAQ:MRNA) unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, enabling a focus on ten …

yahoo.com

Moderna Faces Analyst Downgrades Amid Revised R&D …

2 weeks from now

Sep 14, 2024  · Thursday, Moderna Inc (NASDAQ:MRNA) unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, enabling a focus on ten …

aol.com

Moderna Crashes After Slashing Its R&D Budget By $1.1 Billion

2 weeks from now

Sep 16, 2024  · Moderna stock crashed Thursday after the Covid vaccine maker slashed its R&D budget by $1.1 billion and issued light 2025 sales guidance. The company says its investment …

investors.com

Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut

2 weeks from now

Sep 13, 2024  · Shares of Moderna fell Friday after taking on steep losses a day earlier on the news that it plans to cut research and development spending by $1.1 billion by 2027.

investopedia.com

Moderna's Stock Slides As It Slashes Research Spending

2 weeks from now

Sep 12, 2024  · In early August, Moderna's stock suffered its biggest-ever one-day decline after the company cut its full-year 2024 sales guidance to a range of $3 billion to $3.5 billion, down …

morningstar.com

Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled …

2 weeks from now

Aug 5, 2024  · Moderna stock, which lost 27% of its value over two days last week, tumbled again Monday on a rare downgrade amid increasingly uncertain outlooks for its RSV and Covid …

investors.com

Moderna Stock Plunges As Vaccine Maker Slashes R&D Budget

2 weeks from now

Sep 12, 2024  · In the release, Moderna also said it anticipates fiscal 2025 revenue to be in the range of $2.5 billion to $3.5 billion and sales to grow at a 25% compound annual growth rate …

kiplinger.com

Moderna’s Recent Drop: 4 Reasons Bulls See Opportunity

2 weeks from now

Sep 16, 2024  · Moderna announced on its R&D Day plans to trim its R&D budget by $1.1 billion by 2027, sending its stock to 10-month lows. For bullish investors, here are four reasons to …

nasdaq.com